Faron Pharmaceuticals Oy Holding(s) in Company (6404K)

TIDMFARN TIDMAV.

RNS Number : 6404K

Faron Pharmaceuticals Oy

10 July 2017

 
 For filings with the FCA 
  include the annex 
 For filings with issuer exclude 
  the annex 
 
 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) 
--------------------------------------------------------------------------------------------------------- 
 
 1. Identity of the issuer or                                       Faron Pharmaceuticals Oy 
  the underlying issuer 
  of existing shares to which 
  voting rights are 
  attached: (ii) 
-----------------------------------------------------------------  -------------------------------------- 
 2 Reason for the notification (please tick the appropriate 
  box or boxes): 
--------------------------------------------------------------------------------------------------------- 
 An acquisition or disposal of voting rights 
--------------------------------------------------------------------  ----------------------------------- 
 An acquisition or disposal of qualifying financial 
  instruments which may result in the acquisition 
  of shares already issued to which voting rights 
  are attached 
--------------------------------------------------------------------  ----------------------------------- 
 An acquisition or disposal of instruments with 
  similar economic effect to qualifying financial 
  instruments 
--------------------------------------------------------------------  ----------------------------------- 
 An event changing the breakdown of voting rights 
--------------------------------------------------------------------  ----------------------------------- 
 Other (please 
  specify): 
-----------------------------------------------------------  -------  ----------------------------------- 
 3. Full name of person(s)                                      Aviva plc & its subsidiaries 
  subject to the 
  notification obligation: 
  (iii) 
-------------------------------------------------------------  ------------------------------------------ 
 4. Full name of shareholder(s)                                 Registered Holder: 
  (if different from 3.):(iv) 
                                                                Chase (GA Group) Nominees Limited 
                                                                1,414,752* 
 
                                                                HSBC Global Custody Nominee 
                                                                (UK) Limited 347,410* 
 
                                                                State Street Nominees Limited 
                                                                35,452* 
                                                                * denotes direct interest 
                                                                Chase (GA Group) Nominees Limited 
                                                                71,497 
                                                                Chase Nominees Limited 41,687 
-------------------------------------------------------------  ------------------------------------------ 
 5. Date of the transaction                                     05 July 2017 
  and date on 
  which the threshold is 
  crossed or 
  reached: (v) 
-------------------------------------------------------------  ------------------------------------------ 
 6. Date on which issuer                                        07 July 2017 
  notified: 
-------------------------------------------------------------  ------------------------------------------ 
 7. Threshold(s) that is/are                                    7% to 6% Change at Combined 
  crossed or                                                     Interest Level. Figures are 
  reached: (vi, vii)                                             provided in accordance with 
                                                                 provisions of your company 
                                                                 articles and not in fulfilment 
                                                                 of the requirements of the 
                                                                 Transparency Directive. 
-------------------------------------------------------------  ------------------------------------------ 
 
 
 
 8. Notified details: 
-------------------------------------------------------------------------------------------------------------- 
 A: Voting rights attached to shares (viii, ix) 
-------------------------------------------------------------------------------------------------------------- 
 Class/type           Situation previous              Resulting situation after the 
  of                   to the triggering               triggering transaction 
  shares               transaction 
 
  if possible 
  using 
  the ISIN 
  CODE 
-------------------  ------------------------------  --------------------------------------------------------- 
                      Number              Number      Number        Number of               % of voting 
                       of                  of          of shares     voting                  rights (x) 
                       Shares              Voting                    rights 
                                           Rights 
-------------------  ------------------  ----------  ------------  ----------------------  ------------------- 
                                                      Direct        Direct      Indirect    Direct   Indirect 
                                                                     (xi)        (xii) 
-------------------  ------------------  ----------  ------------  ----------  ----------  -------  ---------- 
 Ordinary 
  Shares 
 
 
  FI4000153309        1,910,798           1,910,798   1,797,614     1,797,614   113,184     6.44%    0.41% 
                     ------------------  ----------  ------------  ----------  ----------  -------  ---------- 
 
 
 B: Qualifying Financial Instruments 
-------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
-------------------------------------------------------------------------------------------------------------- 
 Type of financial    Expiration          Exercise/                 Number of voting        % of voting 
  instrument           date                Conversion                rights that             rights 
                       (xiii)              Period (xiv)              may be 
                                                                     acquired if 
                                                                     the 
                                                                     instrument 
                                                                     is 
                                                                     exercised/ 
                                                                     converted. 
-------------------  ------------------  ------------------------  ----------------------  ------------------- 
 
 
 
 
 C: Financial Instruments with similar economic effect 
  to Qualifying Financial Instruments (xv, xvi) 
----------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
----------------------------------------------------------------------------------------------- 
 Type of financial   Exercise   Expiration   Exercise/     Number of voting     % of voting 
  instrument          price      date         Conversion    rights instrument    rights (xix, 
                                 (xvii)       period        refers to            xx) 
                                              (xviii) 
------------------  ---------  -----------  ------------  -------------------  ---------------- 
                                                                                Nominal   Delta 
------------------  ---------  -----------  ------------  -------------------  --------  ------ 
 
 Total (A+B+C) 
----------------------------------------------------------------------------------------------- 
 Number of voting rights                                   Percentage of voting rights 
--------------------------------------------------------  ------------------------------------- 
 1,910,798                                                 6.85% 
--------------------------------------------------------  ------------------------------------- 
 
 
 9. Chain of controlled undertakings through which the 
  voting rights and/or the 
  financial instruments are effectively held, if applicable: 
  (xxi) 
-------------------------------------------------------------------- 
      The voting rights are managed and controlled by Aviva 
       Investors Global Services Limited, with the following 
       chains of controlled undertakings:- 
 
       Aviva Investors Global Services Limited: 
        *    Aviva plc (Parent Company) 
 
 
        *    Aviva Group Holdings Limited (wholly owned subsidiary 
             of Aviva plc) 
 
 
        *    Aviva Investors Holdings Limited (wholly owned 
             subsidiary of Aviva Group Holdings Limited) 
 
 
        *    Aviva Investors Global Services Limited (wholly owned 
             subsidiary of Aviva Investors Holdings Limited) 
 
 Proxy Voting: 
-------------------------------------------------------------------- 
 10. Name of the proxy holder:                     See Section 4 
------------------------------------------------  ------------------ 
 11. Number of voting rights proxy 
  holder will cease 
  to hold: 
------------------------------------------------  ------------------ 
 12. Date on which proxy holder will 
  cease to hold 
  voting rights: 
------------------------------------------------  ------------------ 
 
 
 
  13. Additional information:      Figures are based on a total 
                                   number of voting rights of 

                                   27,914,544 as per the company's 
                                   Announcement of 1 June 2017. 
-------------------------------  --------------------------------- 
 14. Contact name:                Neil Whittaker, Aviva plc 
-------------------------------  --------------------------------- 
 15. Contact telephone number:    00 44 1603 684420 
-------------------------------  --------------------------------- 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLDMGMNKGVGNZM

(END) Dow Jones Newswires

July 10, 2017 11:51 ET (15:51 GMT)